ELAN — Elanco Animal Health Cashflow Statement
0.000.00%
Last trade - 00:00- $11.47bn
- $14.95bn
- $4.72bn
Annual cashflow statement for Elanco Animal Health, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -472 | -78 | -1,231 | 338 | -232 |
| Depreciation | |||||
| Deferred Taxes | |||||
| Non-Cash Items | 480 | 367 | 1,188 | -496 | 147 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -87 | -462 | -300 | 149 | 99 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Net Change in Other Assets & Liabilities | |||||
| Cash from Operating Activities | 483 | 452 | 271 | 541 | 560 |
| Capital Expenditures | -197 | -184 | -154 | -161 | -276 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Software Development Costs | |||||
| Other Investing Cash Flow Items | -333 | 5 | -15 | 1,319 | -3 |
| Acquisition of Business | |||||
| Sale of Business | |||||
| Sale of Fixed Assets | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -530 | -179 | -169 | 1,158 | -279 |
| Financing Cash Flow Items | 33 | -47 | -6 | -17 | 288 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 210 | -549 | -83 | -1,492 | -275 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 132 | -293 | 7 | 116 | 77 |